Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0792
-0.0002 (-0.25%)
Jul 8, 2026, 3:20 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 97.22 million as of July 8, 2026. Its market cap has decreased by -36.13% in one year.
Market Cap
97.22M
Enterprise Value
104.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 97.22M, a decrease of -87.33%. That is a compound annual growth rate of -46.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 97.22M | -15.20% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 112.20B |
| Coloplast | 88.92B |
| Demant | 59.30B |
| Gubra | 5.24B |
| BioPorto | 559.47M |
| ViroGates | 94.68M |
| Scandinavian Medical Solutions | 87.03M |